2-Chloro-7-methylquinoline-3-carbonitrile, 95+%, 10g

2,6-Bis(2,2,2-trifluoroacetyl)cyclohexanone, 95.0%, 5g

D-Tryptophan>98.0%(HPLC)(T)5g

(piperidin-4-yl)methyl 4-fluoro-4-(hydroxymethyl)piperidine-1-carboxylate hydrochloride, 97.0%, 1g

1-Bromo-2,3,5-trifluorobenzene>98.0%(GC)5g

7-methoxy-2,3-dihydro-1,4-benzodioxine-6-carbaldehyde, 95.0%, 100mg

Crucible adapter, Suitable for, filter crucible 15 ml, 1 Piece

p-Xylene, min. 99%, for synthesis, 500 ml, glass packaging

3-(3-BROMO-PHENYL)-2-METHYL-PROPIONIC ACID, 90.0%, 100mg

1-Ethynylcyclobutan-1-ol, 98%, 5g

3,6-Difluoro-2-methylbenzoic acid, 98+%, 1g

Microliter syringe GASTIGHT® series 1700 Point type 2, 25 µl, 1702 RN, 1 piece

N-(9-((2R,3R,4R,5R)-3-((tert-Butyldimethylsilyl)oxy)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 1g